Biodiversity is declining in the world, and it is getting harder to produce drugs for deadly diseases.
Research conducted at Emory University in Georgia, USA, drew attention to this danger. Accordingly, human beings may have difficulties in finding pharmaceutical raw materials in the future.
According to the World Health Organization, 11 percent of medicines for basic diseases are produced from flowering plants.
‘Biodiversity’ alarm in medicine
The scientific world still cannot synthetically produce some chemicals produced by plants and fungi.
This means that as biodiversity declines, there may be shortages of drugs produced for diseases such as cancer.
The situation is similar for drugs such as penicillin used to treat infections.
The exploitation of natural resources, the development of invasive species, agricultural land misuse and urbanization are the main enemies of biodiversity.
Attention is drawn to sustainable methods
Experts are of the opinion that more sustainable methods should be used in the collection and processing of vital medicinal plants.
Today, the rate of biodiversity decline is progressing up to 10,000 times faster than the natural process.
Wildlife populations have fallen by at least two-thirds in 50 years, according to data from the Wildlife Fund.
One third of the plant and animal species on earth are in danger of extinction.